How to build a biotech renaissance: MIT in Kendall Square
A look back at how Institute Professor Phillip Sharp, his startup Biogen, and MIT’s biotech community helped revive Kendall Square.
A look back at how Institute Professor Phillip Sharp, his startup Biogen, and MIT’s biotech community helped revive Kendall Square.
Sequencing of cancer cell genomes reveals potential new drug targets for an aggressive type of lung cancer.
Michael Hemann seeks better ways to deploy chemotherapy drugs and overcome tumor resistance.
Institute’s programs rank first in 7 engineering, 5 science, and 3 business fields.
Biologists identify extracellular proteins that help aggressive tumors spread through the body.
Senior Suan Tuang, a recent immigrant from Myanmar, excels at MIT in chemistry, cancer research, and leadership.
Work reveals how a genome-editing tool works to correct errors in the genetic code.
Whether she’s blocking shots on the ice or studying cancer cells in the lab, MIT senior Kate Koch tackles challenges head-on.
Professors' research areas include molecular mechanisms in cells, quantum condensed matter, and dark matter.
MIT researcher Shuguang Zhang’s nanofiber-scaffold technology became the foundation for a biotech company.
Linda Griffith combines in vitro models with deep molecular analysis to accelerate drug discovery.
Architect and designer recognized for leading-edge design inspired by biology
Biologists identify a drug that can help wipe out reservoirs of cancer cells in bone marrow.
Study reveals how the brain links memories of events that occur one after the other.
Senior Dylan Soukup has fought cancer on two fronts — and led MIT EMS through deep loss.